人凝血酶原复合物

ATC B02BD · 1 markets · 21 records

人凝血酶原复合物 1 markets · 21 records Forms

CN 21 records · 6 strengths

  • 300 IUinjection康舒宁人凝血酶原复合物Manufacturer: 上海莱士血液制品股份有限公司、Manufacturer: 华兰生物工程重庆有限公司、Manufacturer: 南岳生物制药有限公司、Manufacturer: 博晖生物制药(河北)有限公司、Manufacturer: 同路生物制药有限公司、Manufacturer: 山西康宝生物制品股份有限公司、Manufacturer: 广东卫伦生物制药有限公司、Manufacturer: 成都蓉生药业有限责任公司 +1
  • 200 IUinjection康舒宁人凝血酶原复合物Manufacturer: 上海莱士血液制品股份有限公司、Manufacturer: 南岳生物制药有限公司、Manufacturer: 广东双林生物制药有限公司
  • 400 IUinjection康舒宁人凝血酶原复合物Manufacturer: 上海莱士血液制品股份有限公司、Manufacturer: 华润博雅生物制药集团股份有限公司
  • 300 IU/20 mLinjectionManufacturer: 山东泰邦生物制品有限公司Manufacturer: 贵州泰邦生物制品有限公司
  • 1,000 IUinjectionManufacturer: 上海莱士血液制品股份有限公司 ×5
  • 100 IUinjectionManufacturer: 上海莱士血液制品股份有限公司 ×5
The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.